Expression of membrane cofactor protein (MCP, CD46) in human liver diseases (original) (raw)

References

• Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248
  Article CAS Google Scholar
• Bjørge, L., Hakulinen, J., Wahlström, T., Matre, R. & Meri, S. (1997). Complement-regulatory proteins in ovarian malignancies. Int J Cancer 70: 14–25.
  Article Google Scholar
• Cheung, N-KV, Walter, E. I., Smith-Mensah, W. H., Tatnoff, W. D., Tykocinski, M. L. & Medof, M. E. (1988). Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. J Clin Invest 81: 1122–1128.
  Article CAS Google Scholar
• Davies, A., Simmons, D. L., Hale, G., Harrison, R. A., Tighe, H., Lachmann, P. J. & Waldmann, H. (1989). CD59, an LY-6 like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170: 637–645.
  Article CAS Google Scholar
• Gorter, A., Blok, V. T., Haasnoot, W. H. B., Ensink, N. G., Daha, M. R. & Fleuren, G. J. (1996). Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. Lab Invest 74: 1039–1049.
  CAS PubMed Google Scholar
• Hakulinen, J. & Meri, S. (1994). Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Lab Invest 71: 820–827.
  CAS PubMed Google Scholar
• Hofman, P., Hsi, B-L, Manie, S., Fenichel, P., Thyss, A. & Rossi, B. (1994). High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack? Breast Cancer Res Treat 32: 213–219.
  Article CAS Google Scholar
• Hourcade, D., Kolers, V. M. & Atkinson, J. P. (1989). The regulators of complement activation (RCA) gene cluster. Adv Immunol 45: 381–416.
  Article CAS Google Scholar
• Inoue, H., Mizuno, M., Uesu, T., Ueki, T. & Tsuji, T. (1994). Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer. Acta Med Okayama 48: 271–277.
  CAS PubMed Google Scholar
• Johnstone, R. W., Loveland, B. E. & Mckenzie, I. F. C. (1993). Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 79: 341–347.
  CAS PubMed PubMed Central Google Scholar
• Lachmann, P. J. (1991). The control of homologous lysis. Immunol Today 12: 312–315.
  Article CAS Google Scholar
• Liszewski, M. K., Post, T. W. & Atkinson, J. P. (1991). Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9: 431–460.
  Article CAS Google Scholar
• Liver Cancer Study Group of Japan (1989). The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 19: 98–129.
• Lublin, D. M. & Atkinson, J. P. (1989). Decay-accelerating factor: biochemistry, molecular biology and function. Annu Rev Immunol 7: 35–58.
  Article CAS Google Scholar
• Mäenpää, A., Junnikkala, S., Hakulinen, J., Timonen, T. & Meri, S. (1996). Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas. Am J Pathol 148: 1139–1152.
  PubMed PubMed Central Google Scholar
• Maisner, A., Liszewski, M. K., Atkinson, J. P., Schwartz-Albiez, R. & Herrler, G. (1996). Two different cytoplasmic tails direct isoforms of the membrane cofactor protein (CD46) to the basolateral surface of Madin-Darby canine kidney cells. J Biol Chem 271: 18853–18858.
  Article CAS Google Scholar
• Matsumoto, M., Seya, T. & Nagasawa, S. (1992). Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement. Biochem J 281: 493–499.
  Article CAS Google Scholar
• Matsumura, N., Tagami, H., Hotta, T., Takemura, S., Yoshikawa, T. & Kondo, M. (1981). Serum complement profile and its clinical significance in patients with hepatocellular carcinoma and liver cirrhosis. Nippon Shokakibyo Gakkai Zassi 78: 1753–1759.
  CAS Google Scholar
• McNearney, T., Ballard, L., Seya, T. & Atkinson, J. P. (1989). Membrane cofactor protein of complement is present on human fibroblast, epithelial and endothelial cells. J Clin Invest 84: 538–545.
  Article CAS Google Scholar
• Nagura, H., Hasegawa, H., Yoshimura, S. & Watanabe, K. (1985). The third (C3) and fourth (C4) components of complement in human liver. Immunocytochemical evidence for hepatocytes as the site of synthesis. Acta Pathol Jpn 35: 71–78.
  CAS PubMed Google Scholar
• Niehans, G. A., Cherwitz, D. L., Staley, N. A., Knapp, D. J. & Dalmasso, A. P. (1996). Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay accelerating factor), and CD59 (protectin). Am J Pathol 149: 129–142.
  CAS PubMed PubMed Central Google Scholar
• Scoazec, J-Y, Delautier, D., Moreau, A., Durand, F., Degott, C., Benhamou, J-P, Belghiti, J. & Feldmann, G. (1994). Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology 107: 505–516.
  Article CAS Google Scholar
• Seya, T. & Atkinson, J. P. (1989). Functional properties of membrane cofactor protein of complement. Biochem J 264: 581–588.
  Article CAS Google Scholar
• Seya, T., Hara, T., Matsumoto, M., Sugita, Y. & Akedo, H. (1990). Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med 172: 1673–1680.
  Article CAS Google Scholar
• Seya, T., Matsumoto, M., Hara, T., Hatanaka, M., Masaoka, T. & Akedo, H. (1994). Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies. Leuk Lymphoma 12: 395–400.
  Article CAS Google Scholar
• Simpson, K. L., Houlihan, J. M. & Holmes, C. H. (1993). Complement regulatory proteins in early human fetal life: CD59, membrane cofactor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver. Immunology 80: 183–190.
  CAS PubMed PubMed Central Google Scholar
• Simpson, K. L., Jones, A., Norman, S. & Holmes, C. H. (1997). Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease. Am J Pathol 151: 1455–1467.
  CAS PubMed PubMed Central Google Scholar
• Theodore, W., Post, M., Liszewsky, K., Anams, E. M., Tedja, I., Miller, A. & Atkinson, J. P. (1991). Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 174: 93–102.
  Article Google Scholar

Download references